ATP1A3 and alternating hemiplegia of childhood: Our results provide biological validation for heterozygous missense mutations in ATP1A3 as a cause of AHC in humans, and highlight Myshkin as an aetiologically-relevant model system for the exploration of disease mechanisms and novel treatments in AHC.